市場調查報告書

臨床化驗服務市場 - 成長,趨勢,預測

Clinical Laboratory Services Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 922037
出版日期 內容資訊 英文 114 Pages
商品交期: 2-3個工作天內
價格
臨床化驗服務市場 - 成長,趨勢,預測 Clinical Laboratory Services Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年01月01日內容資訊: 英文 114 Pages
簡介

本報告提供臨床化驗服務的世界市場調查,提供市場概要,各類型,各地區的市場趨勢,市場規模的變化與預測,市場促進·阻礙因素以及市場機會分析,競爭情形,主要企業的簡介等全面性資訊 。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 成長要素
  • 阻礙因素
  • 波特的五力分析
    • 新加入廠商的威脅
    • 消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭

第5章 市場區隔

  • 各試驗類型
    • 臨床化學檢驗
    • 免疫檢驗
    • 細胞診斷檢驗
    • 遺傳基因檢驗
    • 微生物檢驗
    • 血液檢驗
    • 其他
  • 各服務供應商
    • 獨立型·參考實驗室
    • 醫院系實驗室
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Abbott Laboratories
    • Fresenius Medical Care
    • QIAGEN
    • Quest Diagnostics Incorporated
    • Siemens AG
    • Novartis AG
    • LabCorp
    • NeoGenomics
    • Charles River Laboratories
    • OPKO Health

第7章 市場機會及未來趨勢

目錄
Product Code: 67131

Market Overview

The market studied is primarily driven by the rising incidences of chronic diseases and the increasing demand for accurate disease diagnosis, along with the government's focus on public-private partnerships. However, the lack of medical laboratories, advanced diagnostic equipment, and inadequately trained laboratory staff are restraining the market's growth. Most of the developing countries across the globe are facing a high prevalence of communicable diseases along with the rising prevalence of non-communicable diseases. As per the World Health Organization, of the 56.9 million global deaths in 2016, 40.5 million, or 71%, were due to noncommunicable diseases (NCDs). People across the developing countries are becoming more selective about the health services they get. Due to the favorable reimbursement and developed healthcare systems of countries such as the United States, France, the UK, etc., there is a high demand for laboratory services which is propelling the growth of the market studied.

The progression of chronic diseases can be prevented through lifestyle changes. However, the early diagnosis of an underline disease is necessary for interventions to be effective. Thus, owing to the increasing burden of chronic diseases, the volumes of diagnostic tests are expected to increase rapidly, resulting in the expansion of the market.

Scope of the Report

In a clinical laboratory, clinical pathology tests are carried out on collected clinical specimens, for obtaining information about the patient's health, in order to aid in the diagnosis, prevention, and treatment of diseases.

Key Market Trends

Independent Laboratories to Register Healthy Growth

The demand for laboratory testing is increasing, due to the increasing incidences of chronic diseases, thereby increasing the demand for the accurate diagnosis of different diseases. In highly populated countries like India and China where a significant chunk of the population does not have access to proper medical diagnostic facilities, there is a huge opportunity for independent laboratories. In countries like Nigeria, the laboratory services are being integrated with the three-tier public health system at the primary, secondary, and tertiary levels. Besides these, there are reference laboratories, research laboratories, and disease-specific reference laboratories to provide services for complex and special tests.

The independent laboratories are coming up with highly advanced types of equipment and are providing multiple test types that are enabling patients to access the service as per their convenience. Hence, independent laboratories are expected to witness healthy growth.

The United States Holds the Largest Share of the Market

The major factor driving growth of the United States clinical laboratory services market is the presence of key players and the government organizations in the country which enables the awareness among the general population and allows them to access the services conveniently. For instance, the American Clinical Laboratory Association is a not-for-profit organization created in 1971 which offers members the benefits of representation, education, information, and research. Also, the high adoption of technological advancements in the country backed up by proper quality measures is playing an important role in delivering quality, efficient and effective service to the growing healthcare industry.

Competitive Landscape

The market for clinical laboratory services is moderately competitive and various global, as well as local companies, are present in the market. A major share of the market is grabbed by the global players and local companies are also focusing on delivering innovative services to the people which is allowing these companies to establish their considerable place in this market. With a rising need for technology, it is expected that few new entrants will be seen in the market in the future and these players will gain a substantial share.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Technological Advancements in the Clinical Testing
    • 4.2.2 Raised Burden of Target Diseases and Rising Demand for Early Detection
  • 4.3 Market Restraints
    • 4.3.1 Regulatory Issues
    • 4.3.2 Lack of Skilled Professionals
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Test Type
    • 5.1.1 Clinical Chemistry
    • 5.1.2 Immunology
    • 5.1.3 Cytology
    • 5.1.4 Genetic
    • 5.1.5 Microbiology
    • 5.1.6 Hematology
    • 5.1.7 Others
  • 5.2 By Service Provider
    • 5.2.1 Independent and Reference Laboratories
    • 5.2.2 Hospital-based Laboratories
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Fresenius Medical Care
    • 6.1.3 QIAGEN
    • 6.1.4 Quest Diagnostics Incorporated
    • 6.1.5 Siemens AG
    • 6.1.6 Novartis AG
    • 6.1.7 LabCorp
    • 6.1.8 NeoGenomics
    • 6.1.9 Charles River Laboratories
    • 6.1.10 OPKO Health

7 MARKET OPPORTUNITIES AND FUTURE TRENDS